Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
119.31
+2.98 (2.56%)
Sep 17, 2026, 12:32 PM EDT - Market open
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $9.92 billion as of September 17, 2026. Its market cap has increased by 184.45% in one year.
Market Cap
9.92B
Enterprise Value
8.49B
1-Year Change
184.45%
Ranking
Category
Stock Price
$119.31
ChartMarket Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $9.92B, an increase of 1,088.85%. That is a compound annual growth rate of 50.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 9.92B | 59.38% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 10.69B |
| ABIVAX Société Anonyme | 10.02B |
| Arrowhead Pharmaceuticals | 9.98B |
| Krystal Biotech | 9.97B |
| Cytokinetics | 9.64B |
| Protagonist Therapeutics | 9.29B |
| Vaxcyte | 8.81B |
| Praxis Precision Medicines | 8.74B |